Drugs / Acetyl-L-Carnitin
last change Feb 2024 re-read 2 minutes ago

Acetyl-L-Carnitin

Developed for
polycystic ovary syndrome
Investigated by
Khyber Medical University Peshawar

Trials 1 · a red edge is where a trial was stopped

2023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
NCT05653895 Dec 2022 → Dec 2023 polycystic ovary syndrome Khyber Medical University Peshawar Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Acetyl-L-Carnitin ClinicalTrials.gov intervention name — accepted as the source's own label NCT05653895